Last reviewed · How we verify
NCT04694066
Qigong for Pre-frail and Frail Older Cancer Survivors
NA trial testing Qigong in Cancer in 28 participants. Completed in 30 June 2021.
28 February 2021
Quick facts
| Lead sponsor | The University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 28 |
| Start date | 1 August 2019 |
| Primary completion | 28 February 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 2 locations across Hong Kong |
Drugs / interventions tested
- Qigong
- Light flexibility exercise
Conditions studied
Sponsor
The University of Hong Kong
Who can join
Adults 65 to 85, any sex, with Cancer or Frailty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To-date, there is no evidence on qigong's effects for improving well-being of pre-frail and frail older cancer survivors. Our aim is to conduct a pilot study for testing out the feasibility and acceptability of a qigong intervention to the elderly cancer survivors.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A pilot randomized controlled trial using Baduanjin qigong to reverse frailty status among post-treatment older cancer survivors.
Cheung DST, Chau PH, Lam TC, Ng AYM, et al · · 2022 · cited 24× · PMID 35272982 · DOI 10.1016/j.jgo.2022.02.014
Verify or expand the search:
- PubMed search for NCT04694066
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Qigong
Trials testing the same drug.
- NCT06140355 — HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A F · NA · recruiting
- NCT06406283 — Active Young, Healthy Mind. The YoungFitT Project · NA · recruiting
- NCT06804408 — Unpacking the "Mind" and "Body" Pathways of the Antidepressant Effect of Qigong in Older Adults: A Pilot Study · NA · completed
- NCT05675995 — Qigong for Post Acute Sequelae of COVID-19 Infection · NA · completed
- NCT06877325 — Synergistic Effects of Traditional Chinese Medicine Practices and Pelvic Floor Muscle Training · NA · completed
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other The University of Hong Kong trials
Trials by the same sponsor.
- NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
- NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
- NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
- NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04694066 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
- Last refreshed: 22 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04694066.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing